Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
330 participants
INTERVENTIONAL
2006-06-30
2008-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Tailored Communication to Reduce Cardiovascular Risk
NCT01286311
An Interactive Patient-Centered Consent for Research Using Medical Records
NCT03063268
The Effect of Education on Patient Compliance
NCT00376974
Video Messages and Vaccination Intention
NCT04979416
Use of Construal Level Theory to Inform Messaging to Increase Vaccination Against COVID-19
NCT04871776
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
tailored print messages to encourage eye examination behavior
tailored newsletter
Tailored newsletter that addresses each person's stage of change, barriers to getting eye exams, and knowledge of eye exams and eye disease
2
targeted print messages to encourage eye examination behavior
targeted newsletter
Targeted newsletter that contains messages about barriers to getting eye exams and presents facts about glaucoma and African-Americans.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
tailored newsletter
Tailored newsletter that addresses each person's stage of change, barriers to getting eye exams, and knowledge of eye exams and eye disease
targeted newsletter
Targeted newsletter that contains messages about barriers to getting eye exams and presents facts about glaucoma and African-Americans.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* 65 years of age or older
* no dilated fundus exam in past 2 years
Exclusion Criteria
* no access to phone
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Eye Institute (NEI)
NIH
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
University of Maryland, Baltimore
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Nancy J. Ellish, DrPH, MSPH
Role: PRINCIPAL_INVESTIGATOR
University of Maryland, Baltimore
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Maryland School of Medicine
Baltimore, Maryland, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Ellish NJ, Royak-Schaler R, Passmore SR, Higginbotham EJ. Knowledge, attitudes, and beliefs about dilated eye examinations among African-Americans. Invest Ophthalmol Vis Sci. 2007 May;48(5):1989-94. doi: 10.1167/iovs.06-0934.
Ellish NJ, Royak-Schaler R, Higginbotham EJ. Tailored and targeted interventions to encourage dilated fundus examinations in older African Americans. Arch Ophthalmol. 2011 Dec;129(12):1592-8. doi: 10.1001/archophthalmol.2011.190.
Other Identifiers
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.